皮肤肿瘤学实践中衰弱筛查:改良德尔菲研究与系统综述
本研究通过改良两轮德尔菲法在50名意大利和荷兰专家及患者中确定衰弱筛查工具(FST)的需求优先级,并系统检索现有FST进行评估。共识要求FST评估合并症、多重用药和认知,且具备良好测量性能、快速执行、临床相关、易理解与解释。系统综述识别26个FST,其中G8研究最广泛、心理测量性能最佳且5分钟内完成,被认为最适合老年皮肤癌患者衰弱评估。
要点
- G8是老年皮肤癌患者衰弱筛查最合适的工具。
- FST应评估合并症、多重用药和认知。
- G8心理测量性能最佳且5分钟内完成。
核心结论
- G8似乎是评估老年皮肤癌患者衰弱的最合适FST。
- 仍需临床研究评估G8在皮肤肿瘤人群中的应用价值。
研究设计与样本
- 改良两轮德尔菲法在50名意大利和荷兰专家及患者中进行。
- 系统文献检索识别现有多维度FST并进行评估。
主要发现
- 共识达成:评估合并症(4.3±0.7)、多重用药(4.0±0.9)和认知(4.1±0.8)。
- FST应具备适当测量性能(4.0±1.0)、快速执行(4.2±0.7)、临床相关(4.3±0.7)、易理解(4.1±1.2)和易解释(4.3±0.7)。
- 识别26个FST,其中4个评估内容相关域:G8、mG8、GFI和SAOP2。
- G8是研究最广泛的FST,心理测量性能最佳且5分钟内完成。
关键数值与推荐
- 共识定义为平均分≥4.0(5点Likert量表)。
- G8满足内容相关域要求且5分钟内完成。
临床怎么用
- 在皮肤肿瘤学实践中可考虑使用G8进行衰弱筛查。
- G8快速易行,适合老年皮肤癌患者评估。
局限性
- 需要临床研究评估G8在皮肤肿瘤人群中的使用。
- 衰弱是否与相关结局(如并发症和死亡率)关联尚需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Appropriate management and prevention of both under- and overtreatment in older skin cancer patients can be challenging. It could be helpful to incorporate frailty screening in dermato-oncology care, since frailty is associated with adverse health outcomes. OBJECTIVES: This study aimed to identify and prioritize the requirements a frailty screening tool (FST) should fulfil in dermato-oncology practice and to select the best existing FST(s) for this purpose. METHODS: A modified two-round Delphi procedure was performed among 50 Italian and Dutch specialists and patients to review and prioritize a list of potential FST requirements, using a 5-point Likert scale. Consensus was defined as a mean score of ≥4.0. A systematic literature search was performed to identify existing multidomain FSTs, which were then assessed on the requirements resulting from the modified Delphi procedure. RESULTS: Consensus was achieved on evaluation of comorbidities (4.3 ± 0.7), polypharmacy (4.0 ± 0.9) and cognition (4.1 ± 0.8). The FST should have appropriate measurement properties (4.0 ± 1.0), be quickly executed (4.2 ± 0.7), clinically relevant (4.3 ± 0.7), and both easily understandable (4.1 ± 1.2) and interpretable (4.3 ± 0.7). Of the 26 identified FSTs, four evaluated the content-related domains: the Geriatric-8 (G8), the modified Geriatric-8 (mG8), the Groningen Frailty Indicator (GFI) and the Senior Adult Oncology Program 2 (SAOP2) screening tool. Of these, the G8 was the most extensively studied FST, with the best psychometric properties and execution within 5 min. CONCLUSIONS: The G8 appears the most suitable FST for assessing frailty in older adults with skin cancer, although clinical studies assessing its use in a dermato-oncology population are needed to further assess whether or not frailty in this particular patient group is associated with relevant outcomes (e.g. complications and mortality), as seen in previous studies in other medical fields.
引用
- van Winden MEC, Garcovich S, Peris K, et al. Frailty screening in dermato-oncology practice: a modified Delphi study and a systematic review of the literature. J Eur Acad Dermatol Venereol. 2020. PMID: 32403174. doi:10.1111/jdv.16607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。